Janux Therapeutics Inc (JANX)
47.50
-0.41
(-0.86%)
USD |
NASDAQ |
May 15, 16:00
47.50
0.00 (0.00%)
After-Hours: 16:31
Janux Therapeutics Shareholders Equity (Quarterly): 655.76M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 655.76M |
| December 31, 2023 | 344.35M |
| September 30, 2023 | 348.95M |
| June 30, 2023 | 299.47M |
| March 31, 2023 | 311.26M |
| December 31, 2022 | 320.74M |
| September 30, 2022 | 331.51M |
| Date | Value |
|---|---|
| June 30, 2022 | 343.81M |
| March 31, 2022 | 356.08M |
| December 31, 2021 | 366.33M |
| September 30, 2021 | 376.75M |
| June 30, 2021 | 384.80M |
| March 31, 2021 | -16.77M |
| December 31, 2020 | -14.64M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-16.77M
Minimum
Mar 2021
655.76M
Maximum
Mar 2024
314.89M
Average
344.08M
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics Inc | 933.89M |
| Equillium Inc | 21.09M |
| Minerva Neurosciences Inc | -36.59M |
| Arvinas Inc | 609.70M |
| Calidi Biotherapeutics Inc | -8.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 688.98M |
| Total Liabilities (Quarterly) | 33.22M |
| Current Ratio | 62.09 |